It follows an internal racism row and the suspension of the body's chief executive after an investigation into her conduct.
HES can provide the kind of real-world evidence that some life sciences companies have a great deal of difficulty in ...
Positive full results from the NATRON Phase III trial showed AstraZeneca’s FASENRA (benralizumab) demonstrated a statistically significant delay in the time to first worsening or flare in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results